Longvida Vascular Health Study .jpg

Recently Published Human Clinical - positive effects Using Longvida®

Researchers with the University of Colorado clinically investigated Longvida's ability to improve vascular endothelial function, as assessed by endothelium dependent dilation (EDD), in middle-aged and older adults. After 12 weeks of 2000mg per day of Longvida Optimized Curcumin, brachial artery flow-mediated dilation (FMDba) was increased by 36% versus placebo, which showed no change. Results, published in January 2017, indicate that Longvida® improves vascular endothelial function by increasing nitric oxide bioavailability through a reduction in oxidative stress and inflammatory signaling in middle-aged and older adults. According to the authors, these results support evidence that supplementation of Longvida® may be a promising therapeutic option to improve vascular health. Further, this clinical provides additional support for Longvida’s efficacious ability to promote healthy aging. 

Fill out the form to download the complete study.